Bacterial blood infection, computer illustration. Researchers compared outcomes of continuous vs intermittent meropenem among critically ill patients with sepsis. Clinical outcomes among critically ...

Meropenem has been approved by the Food and Drug Administration (FDA) for the treatment of abdominal infections in infants <3 months old. The approval was based on an open-label, multiple-dose study ...

Purpose: The stability of meropenem in i.v. solutions stored in polyvinyl chloride (PVC) bags and an elastomeric infusion device at concentrations commonly used in home care was studied. Methods: ...

Credit: Getty Images. Shionogi has announced positive results from the phase 3 APEKS-NP trial of cefiderocol (S-649266) for the treatment of nosocomial pneumonia. Shionogi has announced positive ...

Cefepime-taniborbactam, an investigational beta-lactam and beta-lactamase inhibitor combination, was superior to meropenem for the treatment of hospitalized patients with complicated urinary tract ...

Learn everything you need to know about Meropenem-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Review the side-effects of Meropenem as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Cefiderocol, a novel siderophore cephalosporin, was noninferior to high-dose meropenem for the ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved the antibiotic meropenem for the treatment of abdominal infections in neonates and ...